Home » Drug Information » Recently Approved Drugs » 1997
Medical Areas: Dermatology/Plastic Surgery
Drug Information
The following information is obtained from various newswires, published
medical journal articles, and medical conference presentations.
Company: Morton Grove Pharmaceuticals
Approval Status: Approved July 1997
Treatment Area: acne vulgaris
Morton Grove Pharmaceuticals' Clindamycin Phosphate Topical
Solution USP 1%, an antibiotic for the treatment of acne vulgaris,
has been approved by the FDA. According to the FDA approval letter,
Morton Grove Pharmaceuticals' product was found to be
equivalent to CLEOCIN Topical Solution 1%, marketed by Pharmacia
& Upjohn Company.
